Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Henkel AG and Co KGaA | 95 |
| 2 | Toyobo Co Ltd | 64 |
| 3 | Dow Chemical Co | 57 |
| 4 | Chevron Phillips Chemical Co LP | 34 |
| 5 | Novartis AG | 29 |
| 6 | Ajinomoto Co Inc | 27 |
| 7 | RJ Reynolds Tobacco Co | 27 |
| 8 | Cohbar Inc | 22 |
| 9 | Bayer AG | 21 |
| 10 | L'Oréal SA | 21 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 450 |
| 2 | C07D | Heterocyclic compounds | 425 |
| 3 | A61P | Therapeutic activity (drug indications) | 396 |
| 4 | C07C | Acyclic and carbocyclic compounds | 240 |
| 5 | C12P | Fermentation, enzyme processes | 238 |
| 6 | C12N | Microorganisms, enzymes | 208 |
| 7 | C08G | Polymers from non-vinyl bonds (e.g. polyamides, polyesters) | 197 |
| 8 | A61Q | Cosmetics, personal care | 164 |
| 9 | G01N | Investigating / analysing materials | 94 |
| 10 | C12Y | Enzyme nomenclature (EC numbers) | 88 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections | 2001 | CHEGE JOSEPH | 8 |
| Preparation of 3-amino-4-hydroxybenzoic acids | 1986 | Dow Chemical Co | 5 |
| Preparation of 3-amino-4-hydroxybenzoic acids | 1989 | Toyobo Co Ltd | 4 |
| PREPARATION OF 3-AMINO-4-HYDROXYBENZOIC ACIDS | 1989 | Dow Chemical Co | 2 |
| Escherichia coli capable of producing 3-amino-4-hydroxybenzoic acid | 2017 | Ajinomoto Co Inc | 1 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Microbial Metabolic Engineering and Bioproduction | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Yasuo Ohnishi | The University of Tokyo | 9 |
| 2 | Sueharu Horinouchi | The University of Tokyo | 5 |
| 3 | Akihiko Kondo | Kobe University | 3 |
| 4 | Chiaki Ogino | Kobe University | 3 |
| 5 | Hideo Kawaguchi | Kobe University | 3 |
| 6 | Hirokazu Suzuki | The University of Tokyo | 3 |
| 7 | Yohei Katsuyama | The University of Tokyo | 3 |
| 8 | Yoshinori Sugai | The University of Tokyo | 3 |
| 9 | Akio Noguchi | The University of Tokyo | 2 |
| 10 | Heinz G. Floss | University of Washington | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| A nitrous acid biosynthetic pathway for diazo group formation in bacteria | 2015 | 131 | Microbial Natural Products and Biosynthesis |
| Effect of vanillic acid on COQ6 mutants identified in patients with coenzyme Q10 deficiency | 2013 | 76 | Advanced battery technologies research |
| Biochemical and Genetic Insights into Asukamycin Biosynthesis | 2010 | 66 | Microbial Natural Products and Biosynthesis |
| Interaction of mushroom tyrosinase with aromatic amines, o-diamines and o-aminophenols | 2004 | 52 | Phytochemicals and Antioxidant Activities |
| Kinetic and Chemical Mechanism of Arylamine<i>N</i>-Acetyltransferase from<i>Mycobacterium tuberculosis</i> | 2008 | 42 | Tuberculosis Research and Epidemiology |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Cheetan?
Which organizations hold the most patents involving this compound?
What are the key research applications documented in the patent literature?
What scientific research topics are associated with this compound?
What is the current patent activity trend for this compound?